Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morie Gertz

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patientsArtur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
BMC Family Practice|September 24, 2020
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitionerMorie Gertz, David Adams, Yukio Ando, et al.
Neurology and Therapy|February 27, 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyTeresa Coelho, Yukio Ando, Merrill D Benson, et al.
Journal of Neurology|December 20, 2019
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosisTeresa Coelho, Aaron Yarlas, Marcia Waddington-Cruz, et al.
American Journal of Hematology|June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple MyelomaKenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Leukemia & Lymphoma|July 15, 2020
Predictors of short-term survival in Waldenström MacroglobulinemiaGordon Ruan, Saurabh Zanwar, Jithma P Abeykoon, et al.
Blood Cancer Journal|March 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapyJoselle Cook, Supriya Gupta, Nadine Abdallah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging SystemJahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, et al.
Orphanet Journal of Rare Diseases|May 7, 2021
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableThomas H Brannagan, Michaela Auer-Grumbach, John L Berk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2020
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statementDavid P Al-Adra, Laura Hammel, John Roberts, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patientsArtur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
BMC Family Practice|September 24, 2020
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitionerMorie Gertz, David Adams, Yukio Ando, et al.
Neurology and Therapy|February 27, 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyTeresa Coelho, Yukio Ando, Merrill D Benson, et al.
Journal of Neurology|December 20, 2019
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosisTeresa Coelho, Aaron Yarlas, Marcia Waddington-Cruz, et al.
American Journal of Hematology|June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple MyelomaKenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
Leukemia & Lymphoma|July 15, 2020
Predictors of short-term survival in Waldenström MacroglobulinemiaGordon Ruan, Saurabh Zanwar, Jithma P Abeykoon, et al.
Blood Cancer Journal|March 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapyJoselle Cook, Supriya Gupta, Nadine Abdallah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging SystemJahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, et al.
Orphanet Journal of Rare Diseases|May 7, 2021
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableThomas H Brannagan, Michaela Auer-Grumbach, John L Berk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2020
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statementDavid P Al-Adra, Laura Hammel, John Roberts, et al.
Pageof 12